comunicato stampa
First own Gerresheimer Autoinjector - Gerresheimer and Midas Pharma announce strategic partnership
- Gerresheimer's first own IP autoinjector suitable for both small and large molecules enhances broad portfolio of solutions, medical devices and pharmaceutical primary packaging
